Literature DB >> 7250700

Development of brief measures of psychological adjustment to medical illness applied to cancer patients.

G R Morrow, M Feldstein, L M Adler, L R Derogatis, A J Enelow, C Gates, J Holland, N Melisaratos, B J Murawski, D Penman, A Schmale, M Schmitt, I Morse.   

Abstract

The interrater reliability and validity of brief interview rated measures of psychosocial adjustment were examined in four sequential studies. A total of 25 videotaped interviews with cancer patients were rated by 105 social workers, nurses, physicians, and specialists in psychosocial oncology. The Rating of Psychosocial Function (RPF), Coping Adequacy Rating (CAR), and Global Adjustment to Illness Scale (GAIS) were used by various rating groups with an indication of interrater agreement. Agreement on ratings was not influenced by the length of interview (15 vs. 30 minutes) but appeared to the affected by the structure of the interview and profession of the raters. All three instruments showed a measure of matching with clinical impressions in addition to demonstrating a measure of both convergent and divergent construct validation. The GAIS was chosen as most adequately reflecting their clinical impression by a majority of raters. With a degree of training, any of the three instruments could be used to assess psychosocial adjustment with some measure of confidence in the validity of the rating.

Entities:  

Mesh:

Year:  1981        PMID: 7250700     DOI: 10.1016/0163-8343(81)90048-7

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  2 in total

1.  Rehabilitation needs and breast cancer: the first month after primary therapy.

Authors:  P A Ganz; C C Schag; M L Polinsky; R L Heinrich; V F Flack
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

2.  Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC).

Authors:  G R Morrow; J Lindke; P Black
Journal:  Qual Life Res       Date:  1992-10       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.